Single-Use Negative Pressure Wound Therapy Devices Market is expected to reach US$ 892.32 million by 2028


PRESS RELEASE BY The Insight Partners 23 May 2022

Share this press on


Traumatic Segment to Hold Largest Share of Wound Type Segment During 2021–2028

According to our new research study on "Single-Use Negative Pressure Wound Therapy Devices Market Forecast to 2028 – COVID-19 Impact and Analysis – by Wound Type and End User," the market is expected to reach US$ 892.32 million by 2028 from US$ 498.32 million in 2021; it is estimated to register a CAGR of 8.8% from 2021 to 2028. The report highlights trends prevailing in the market and drivers and hindrances pertaining to the market growth. Increasing cases of burns, rising rate of c-section surgeries leading to increasing postoperative usage of single-use NPWT devices, and increasing incidence of chronic diseases are the key factors driving the market growth. However, the complications associated with single-use negative pressure wound therapy (NPWT) devices restrain the market growth.

The global single-use negative pressure wound therapy devices market, based on wound type, has been segmented into ulcers, surgical, traumatic, sports injuries, flaps and grafts, and burns. In 2022, the traumatic segment accounted for the largest share of the market; it is further expected to continue its dominance over the forecast period. This type of wound is most common owing to the increasing prevalence of road accidents and trauma cases. Moreover, the traumatic segment is expected to register the highest CAGR in the single-use negative pressure wound therapy devices market during 2021–2028.

North America region secures a substantial share of the global single-use negative pressure wound therapy devices market. The healthcare systems in the US and Canada promotes the use of advanced technology. Further, the region houses some of the major market players. Moreover, increasing prevalence of wounds owing to various conditions, increase in the per capita healthcare expenditure, and new product launches in the region are few more factors contributing to the growth of the market in this region. Moreover, FDA approvals of these devices are also expected to create ample opportunities for the market growth in the region. However, Asia Pacific is expected to be the fastest growing region in the global single-use negative pressure wound therapy devices market. The growth of the market in this region is attributed to the factors such as large geriatric population in countries including China and Japan; increasing prevalence of chronic conditions such as diabetic foot ulcer, surgeries and others; developing healthcare infrastructure and significant technological advancement in countries such as China, and India. Thus, there is a huge potential for the growth of single-use negative pressure wound therapy devices market in Asia Pacific during the forecast period.

Cardinal Health Inc; ConvaTec Group Plc; Carilex Medical; Genadyne Biotechnologies, Inc.; H and R Healthcare; Lohmann & Rauscher GmbH & Co. KG; Medela AG; Mölnlycke Health Care AB; Paul Hartmann Ag; and Smith & Nephew plc are among the leading companies operating in the single-use negative pressure wound therapy devices market. These companies are adopting inorganic and organic growth strategies to expand their global footprints and product portfolio to meet the rising demands for single-use negative pressure wound therapy devices. In March 2020, Smith+Nephew launched its new PICO 14 Single Use Negative Pressure Wound Therapy System. It has a pump duration of up to 14 days. The pump is based on previous PICO sNPWT variants' innovations and advantages. The pump is so enhanced that it requires less user intervention.

Single-Use Negative Pressure Wound Therapy Devices Market, by Region, 2021(%)

Single-Use Negative Pressure Wound Therapy Devices Market, by Region, 2021(%)

Single-Use Negative Pressure Wound Therapy Devices Market Global Report 2028

Download Free Sample

Single-Use Negative Pressure Wound Therapy Devices Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Wound Type (Ulcers, Surgical, Traumatic, Sports Injuries, Flaps and grafts, and Burns) and End User (Hospitals, Clinics, Ambulatory Surgical Centers, and Others)


In terms of wound type, the single-use negative pressure wound therapy devices market is segmented into ulcers, surgical, traumatic, sports injuries, flaps and grafts, and burns. By end user, the market is categorized into hospitals, clinics, ambulatory surgical centers, and others. Geographically, the single-use negative pressure wound therapy devices market is segmented into North America (the US, Canada, and Mexico), Europe (France, Germany, the UK, Spain, Italy, and the Rest of Europe), Asia Pacific (China, India, Japan, Australia, South Korea, and the Rest of APAC), the Middle East & Africa (Saudi Arabia, the UAE, South Africa, and the Rest of MEA), and South & Central America (Brazil, Argentina, and the Rest of South & Central America).

Contact Us
 
Phone: +1-646-491-9876
Email Id: sales@theinsightpartners.com

Download Free PDF Brochure